IBDEI30M ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48152,1,3,0)
 ;;=3^Diabetes Type 2 w/ Mod Nonp Rtnop w/o Macular Edema,Bilateral
 ;;^UTILITY(U,$J,358.3,48152,1,4,0)
 ;;=4^E11.3393
 ;;^UTILITY(U,$J,358.3,48152,2)
 ;;=^5138345
 ;;^UTILITY(U,$J,358.3,48153,0)
 ;;=E11.3411^^185^2417^43
 ;;^UTILITY(U,$J,358.3,48153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48153,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/ Macular Edema,Right Eye
 ;;^UTILITY(U,$J,358.3,48153,1,4,0)
 ;;=4^E11.3411
 ;;^UTILITY(U,$J,358.3,48153,2)
 ;;=^5138347
 ;;^UTILITY(U,$J,358.3,48154,0)
 ;;=E11.3412^^185^2417^44
 ;;^UTILITY(U,$J,358.3,48154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48154,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/ Macular Edema,Left Eye
 ;;^UTILITY(U,$J,358.3,48154,1,4,0)
 ;;=4^E11.3412
 ;;^UTILITY(U,$J,358.3,48154,2)
 ;;=^5138348
 ;;^UTILITY(U,$J,358.3,48155,0)
 ;;=E11.3413^^185^2417^45
 ;;^UTILITY(U,$J,358.3,48155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48155,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/ Macular Edema,Bilaterral
 ;;^UTILITY(U,$J,358.3,48155,1,4,0)
 ;;=4^E11.3413
 ;;^UTILITY(U,$J,358.3,48155,2)
 ;;=^5138349
 ;;^UTILITY(U,$J,358.3,48156,0)
 ;;=E11.3491^^185^2417^46
 ;;^UTILITY(U,$J,358.3,48156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48156,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/o Macular Edema,Right Eye
 ;;^UTILITY(U,$J,358.3,48156,1,4,0)
 ;;=4^E11.3491
 ;;^UTILITY(U,$J,358.3,48156,2)
 ;;=^5138351
 ;;^UTILITY(U,$J,358.3,48157,0)
 ;;=E11.3492^^185^2417^47
 ;;^UTILITY(U,$J,358.3,48157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48157,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/o Macular Edema,Left Eye
 ;;^UTILITY(U,$J,358.3,48157,1,4,0)
 ;;=4^E11.3492
 ;;^UTILITY(U,$J,358.3,48157,2)
 ;;=^5138352
 ;;^UTILITY(U,$J,358.3,48158,0)
 ;;=E11.3493^^185^2417^48
 ;;^UTILITY(U,$J,358.3,48158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48158,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/o Macular Edema,Bilateral
 ;;^UTILITY(U,$J,358.3,48158,1,4,0)
 ;;=4^E11.3493
 ;;^UTILITY(U,$J,358.3,48158,2)
 ;;=^5138353
 ;;^UTILITY(U,$J,358.3,48159,0)
 ;;=E11.3511^^185^2417^37
 ;;^UTILITY(U,$J,358.3,48159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48159,1,3,0)
 ;;=3^Diabetes Type 2 w/ Prolif Rtnop w/ Macular Edema,Right Eye
 ;;^UTILITY(U,$J,358.3,48159,1,4,0)
 ;;=4^E11.3511
 ;;^UTILITY(U,$J,358.3,48159,2)
 ;;=^5138355
 ;;^UTILITY(U,$J,358.3,48160,0)
 ;;=E11.3512^^185^2417^38
 ;;^UTILITY(U,$J,358.3,48160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48160,1,3,0)
 ;;=3^Diabetes Type 2 w/ Prolif Rtnop w/ Macular Edema,Left Eye
 ;;^UTILITY(U,$J,358.3,48160,1,4,0)
 ;;=4^E11.3512
 ;;^UTILITY(U,$J,358.3,48160,2)
 ;;=^5138356
 ;;^UTILITY(U,$J,358.3,48161,0)
 ;;=E11.3513^^185^2417^39
 ;;^UTILITY(U,$J,358.3,48161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48161,1,3,0)
 ;;=3^Diabetes Type 2 w/ Prolif Rtnop w/ Macular Edema,Bilateral
 ;;^UTILITY(U,$J,358.3,48161,1,4,0)
 ;;=4^E11.3513
 ;;^UTILITY(U,$J,358.3,48161,2)
 ;;=^5138357
 ;;^UTILITY(U,$J,358.3,48162,0)
 ;;=E11.3551^^185^2417^50
 ;;^UTILITY(U,$J,358.3,48162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48162,1,3,0)
 ;;=3^Diabetes Type 2 w/ Stable Prolif Rtnop,Right Eye
 ;;^UTILITY(U,$J,358.3,48162,1,4,0)
 ;;=4^E11.3551
 ;;^UTILITY(U,$J,358.3,48162,2)
 ;;=^5138371
 ;;^UTILITY(U,$J,358.3,48163,0)
 ;;=E11.3552^^185^2417^51
 ;;^UTILITY(U,$J,358.3,48163,1,0)
 ;;=^358.31IA^4^2
